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Protein ubiquitination in eukaryotic cells is mediated by
diverse E3 ligase enzymes that each target speciﬁc substrates.
The cullin E3 ligase complexes are the most abundant class of
E3 ligases; they contain various cullin components that serve
as scaffolds for interaction with substrate-recruiting adaptor
proteins. SPOP is a BTB-domain adaptor of the cullin-3 E3
ligase complexes; it selectively recruits substrates via its
N-terminal MATH domain, whereas its BTB domain mediates
dimerization and interactions with cullin-3. It has recently
been recognized that the high-order oligomerization of SPOP
enhances the ubiquitination of substrates. Here, a dimeriza-
tion interface in the SPOP C-terminus is identiﬁed and it is
shown that the dimerization interfaces of the BTB domain
and of the C-terminus act independently and in tandem to
generate high-order SPOP oligomers. The crystal structure of
the dimeric SPOP C-terminal domain is reported at 1.5 A˚
resolution and it is shown that Tyr353 plays a critical role in
high-order oligomerization. A model of the high-order SPOP
oligomer is presented that depicts a helical organization that
could enhance the efﬁciency of substrate ubiquitination.
Received 25 March 2013
Accepted 8 May 2013
PDB References: SPOP270–374
L273D L282D L285K, 4hs2;
SPOP169–374 Y353E, 4j8z
1. Introduction
Ubiquitination is a highly regulated post-translational modi-
ﬁcation that targets proteins for degradation by the 26S
proteasome and also plays nonproteolytic roles in controlling
protein–protein interactions, subcellular localization and
enzymatic activity (reviewed in Komander & Rape, 2012). It is
carried out by an enzyme cascade in which ubiquitin is ﬁrst
transferred from an E1 activating enzyme onto an E2 conju-
gating enzyme. An E3 ubiquitin–protein ligase then catalyses
the transfer of ubiquitin from the E2 enzyme to the substrate.
E3 ligases of the HECT (homologous to the E6AP carboxyl
terminus) domain family contain an active-site cysteine that
forms an obligate thioester intermediate with ubiquitin; in
contrast, the RING (really interesting new gene) ﬁnger E3
ligases do not form a catalytic intermediate with ubiquitin, but
instead act to bring the substrate and E2 enzyme into close
proximity to facilitate ubiquitin transfer. There are approxi-
mately 30 HECT-domain E3s and over 600 RING-ﬁnger
E3s in mammals, and this diversity allows the independent
ubiquitination of different substrates. The regulated
ubiquitination of speciﬁc proteins is critical for fundamental
biological processes such as the cell cycle and apoptosis, and
alterations in ubiquitination pathways have been implicated in
many human disease states (reviewed in Nalepa et al., 2006;
Petroski, 2008).
The cullin–RING E3 ligase complexes are multisubunit
enzymes that together constitute the largest subclass of
RING-ﬁnger E3 ligases. They contain a cullin component
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(Cul1, Cul2, Cul3, Cul4a, Cul4b, Cul5 or Cul7) together with
various adaptor modules that selectively recognize speciﬁc
substrates. The N-termini of the cullins interact with the
adaptors, whereas their C-termini interact with a RING-
domain protein that in turn recruits the E2 enzyme (reviewed
in Zimmerman et al., 2010). The Cul3 adaptors (reviewed in
Pintard et al., 2004) recruit substrates via domains such as
Kelch or MATH (mephrin and TRAF homology), and they
interact with cullin via their BTB [bric-a`-brac, tramtrack and
broad complex; also known as POZ (poxvirus and zinc ﬁnger)]
domain, a versatile protein–protein interaction domain that
is also found in zinc-ﬁnger transcription factors (reviewed in
Stogios et al., 2005).
SPOP (speckle-type POZ protein) is a MATH-BTB-type
Cul3 adaptor that regulates cell proliferation and develop-
ment (Nagai et al., 1997). The MATH domain of SPOP
interacts with serine/threonine-rich degrons in target proteins
(Zhang et al., 2009; Zhuang et al., 2009) that include the
apoptotic regulator Daxx (Kwon et al., 2006), the steroid
receptor co-activator SRC-3 (Li et al., 2011) and the variant
histone protein MacroH2A (Takahashi et al., 2002). SPOP has
been implicated both as an oncogene (Liu et al., 2009; Kim et
al., 2011) and as a tumour suppressor (Barbieri et al., 2012; Li
et al., 2011) in human cancer.
Substrate ubiquitination is enhanced by the self-association
of various E3 ligase components (reviewed in Zimmerman et
al., 2010), and structures of parts of the Cul3 adaptors SPOP
and gigaxonin (Zhuang et al., 2009) revealed BTB-mediated
dimers that resemble the BTB-domain dimers found in tran-
scription factors. Many SPOP substrates contain multiple
weak degrons that may simultaneously bind to the two MATH
domains of an SPOP dimer (Zhang et al., 2009; Zhuang et al.,
2009), thereby enhancing ubiquitination. Although the
dimerization properties of BTB domains have been well
characterized, it is recognized that higher-order oligomeriza-
tion is important for the activities of several BTB proteins
(see, for example, Espina´s et al., 1999), and it has recently been
shown that the high-order oligomerization of SPOP leads
to enhanced substrate ubiquitination by Cul3 E3 ligase
complexes (Errington et al., 2012); the structural basis of these
important high-order associations is unknown. Here, we
identify a novel dimerization interface in the C-terminus of
SPOP that, in concert with the BTB domain, directs the
formation of high-order oligomers. The X-ray crystal structure
of the SPOP C-terminal domain enables us to propose a model
of the high-order SPOP oligomer that reveals the mechanism
by which substrate ubiquitination is enhanced by adaptor
oligomerization.
2. Materials and methods
2.1. Cloning
A cDNA encoding human SPOP residues 1–374 was
ampliﬁed by PCR from a human placental cDNA library.
SPOP fragments were cloned into pGEX-6P-1 (GE Health-
care) for bacterial expression of GST-fusion proteins. Point
mutations and deletions were generated by PCR using
Phusion High-Fidelity DNA polymerase (Thermo Scientiﬁc).
The SPOP proteins expressed in bacteria were SPOP169–374,
SPOP169–334, SPOP169–296, SPOP169–359, SPOP169–355, SPOP169–344,
SPOP169–374 Y353E and SPOP270–374 L273D L282D L285K.
2.2. Protein expression and purification
GST-SPOP proteins were expressed in Escherichia coli
BL21 (DE3) pLysS. Recombinant proteins were induced with
0.1 mM IPTG at 289 K. Bacteria were lysed using a cell
disrupter (Constant Systems), the fusion proteins were bound
to glutathione-Sepharose 4B (GE Healthcare) and the
N-terminal GST tag was removed by cleavage with PreScis-
sion protease in 20 mM Tris–HCl, 75 mM NaCl, 5 mM DTT
pH 7.5. SPOP proteins were further puriﬁed by size-exclusion
chromatography on a Superdex 75 HiLoad 26/60 column (GE
Healthcare) in 20 mM Tris–HCl, 150 mM NaCl, 5 mM DTT,
5% glycerol pH 8.6. Protein preparations for crystallization
were concentrated using Vivaspin centrifugal concentrators
(Sartorius). Selenomethionine-substituted GST-SPOP was
expressed in E. coli B834 (DE3) pLysS; the cells were cultured
in minimal medium in which the methionine was substituted
by 45 mg ml1 l-selenomethionine.
2.3. Crystallization
Crystals of native SPOP270–374 L273D L282D L285K were grown
at 291 K by hanging-drop vapour diffusion against 26% PEG
1500, 0.1M imidazole pH 6.5, 0.1M CaCl2, 7% 2-propanol;
drops were prepared by mixing 2 ml reservoir solution with
1 ml 8 mg ml1 protein solution. Crystals grew to average
dimensions of 150  25  25 mm within 5 d. Crystals of sele-
nomethionine-substituted SPOP270–374 L273D L282D L285K were
grown by hanging-drop vapour diffusion against 29% PEG
1500, 0.1M imidazole pH 6.5, 0.1M CaCl2, 7% 2-propanol.
Crystals of SPOP169–374 Y353E were grown at 291 K by sitting-
drop vapour diffusion against 32% PEG 3350, 17%
2-propanol, 0.1M Tris–HCl pH 8.5; drops were prepared by
mixing 2 ml reservoir solution with 2 ml 16 mg ml1 protein
solution and crystals grew to average dimensions of 200  200
 15 mm within 2 d. Crystals of SPOP270–374 L273D L282D L285K
were cryoprotected by transfer for 30 s into mother liquor
supplemented with 20% glycerol before being ﬂash-cooled in
liquid nitrogen; crystals of SPOP169–374 Y353E were cryopro-
tected with mother liquor supplemented with 19% ethylene
glycol.
2.4. X-ray data collection and structure determination
X-ray data were collected on Diamond Light Source
beamlines I02 (native SPOP270–374 L273D L282D L285K), I04-1
(selenomethionine-substituted SPOP270–374 L273D L282D L285K)
and I03 (native SPOP169–374 Y353E). X-ray data were processed,
reduced and scaled using XDS (Kabsch, 2010) and SCALA
(Evans, 2006) or AIMLESS using the xia2 pipeline (Winter,
2010). The structure of SPOP270–374 L273D L282D L285K
was determined by SAD phasing using SHELXD (Sheldrick,
2008; Schneider & Sheldrick, 2002) for the heavy-atom
research papers
1678 van Geersdaele et al.  SPOP Acta Cryst. (2013). D69, 1677–1684
electronic reprint
search and SHELXE for initial phase estimation and density
modiﬁcation. The phases were combined with native ampli-
tudes and an initial model was built using ARP/wARP (Cohen
et al., 2008). The structure of SPOP169–374 Y353E was solved by
molecular replacement using Phaser (McCoy et al., 2007) with
the human SPOP BTB domain (PDB entry 3htm; chain A
residues 177–299; Zhuang et al., 2009) and human SPOP CTD
(structure of SPOP270–374 L273D L282D L285K; residues 300–359)
as independent search models. The model was built using
ARP/wARP (Cohen et al., 2008) and underwent density
modiﬁcation using Parrot (Zhang et al., 1997). The models of
SPOP270–374 L273D L282D L285K and SPOP169–374 Y353E underwent
several rounds of iterative reﬁnement in REFMAC5
(Murshudov et al., 2011) and model building using Coot
(Emsley et al., 2010). The ﬁnal models consist of SPOP resi-
dues 296–359 (SPOP270–374 L273D L282D L285K) and 178–356
(SPOP169–374 Y353E). Stereochemistry was analysed with
MolProbity (Chen et al., 2010). Structure superpositions were
calculated using the SuperPose server (Maiti et al., 2004) and
buried surface areas and residue contacts were obtained using
the PISA server (Krissinel & Henrick, 2007). Illustrations of
protein structures were prepared using CCP4mg (McNicholas
et al., 2011).
2.5. Chemical cross-linking of purified SPOP proteins
Protein was puriﬁed by size-exclusion chromatography in
PBS and cross-linked by incubation with 6 mM N-hydroxy-
sulfosuccinimide, 6 mM 1-ethyl-3-(3-dimethylaminopropyl)-
carbodiimide hydrochloride for 2 h at 294 K.
2.6. Atomic force microscopy
A freshly cleaved mica surface was incubated for 10 min
in 5 mM MgCl2, brieﬂy rinsed with deionized water
(18.2 M cm1) and dried in a stream of N2 gas; Mg
2+ modi-
ﬁes the negatively charged mica surface, thus assisting the
binding of SPOP protein, which is also negatively charged at
neutral pH. Puriﬁed SPOP169–374 was diluted to 1 mg ml1 in
PBS pH 7.4 supplemented with 5 mM MgCl2, and the mica
surface was incubated for 30 min with 50 ml of the diluted
protein. The disc was gently and brieﬂy washed with deionized
water (18.2 M cm1) and dried in a stream of N2 gas.
The sample was imaged using a Multimode 8 atomic force
microscope (Bruker) using PPP-NCLR probes (Nanosensors;
resonant frequency 170 kHz). Images were acquired in
attractive-regime amplitude-modulation tapping mode, oper-
ating with small r.m.s. amplitudes of <0.15 V. The images
shown are from two independently puriﬁed samples of SPOP
protein; each batch was imaged at least three times. Data were
analysed and processed using NANOSCOPE ANALYSIS
v.1.40r1 (Bruker).
3. Results
3.1. Crystal structure of the SPOP C-terminal domain
Human SPOP is a 374-residue protein that contains an
N-terminal MATH domain (residues 28–166) that recruits
substrates and a central BTB domain (residues 177–296) that
mediates dimerization and interactions with Cul3 (Fig. 1a).
The SPOP C-terminus is predicted to contain an -helical
region (residues 298–359) and a basic nuclear localization
signal (NLS; residues 365–374), and it has recently been shown
that the C-terminus is involved in dynamic high-order oligo-
merization (Errington et al., 2012). To analyse the oligomer-
ization properties of the SPOP C-terminus, we expressed
SPOP169–374, which contains the BTB domain together with
the C-terminus, in E. coli. The puriﬁed protein eluted as a
high-molecular-weight species (>100 kDa) upon size-
exclusion chromatography, and chemical cross-linking of the
protein produced high-order oligomers (Supplementary
Fig. S1a1). In contrast, the puriﬁed BTB domain, SPOP169–296,
was dimeric, as was a protein that contained an incomplete
C-terminus (SPOP169–334), suggesting that the C-terminal
residues 335–374 are required for high-order oligomerization
(Supplementary Fig. S1a). To study the C-terminus of
SPOP in isolation from the BTB domain, we puriﬁed
SPOP270–374 L273D L282D L285K, which contains the two C-
terminal -helices (5 and 6) of the BTB domain together
with the entire SPOP C-terminus; the solubility of this protein
was increased by the mutation of three surface-exposed
hydrophobic residues of 5 and 6. SPOP270–374 L273D L282D L285K
was dimeric when analysed by size-exclusion chromatography
and chemical cross-linking (Supplementary Fig. S1b),
suggesting that the SPOP C-terminus contains a dimerization
interface that is independent of the BTB domain.
To elucidate the mechanism of the high-order oligomer-
ization of SPOP, we determined the X-ray crystal
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Figure 1
Crystal structure of the SPOP C-terminal domain (CTD). (a) Domain
organization of human SPOP. (b) Cartoon representation of the SPOP
CTD dimer. The two chains are coloured blue and cyan. Secondary-
structure elements of the B chain and interacting residues of the
dimerization interface are indicated; residues of the B chain are indicated
with a prime.
1 Supplementary material has been deposited in the IUCr electronic archive
(Reference: MH5093). Services for accessing this material are described at the
back of the journal.
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structure of the C-terminus at 1.5 A˚ resolution. The
SPOP270–374 L273D L282D L285K dimer crystallized with a
monomer in the asymmetric unit; the dimer was revealed from
crystallographic symmetry (Table 1, Fig. 1b and Supplemen-
tary Fig. S2). No electron density was observed for the resi-
dues comprising the predicted nuclear localization signal
(residues 360–374) and BTB 5–6 (residues 270–295), and
they were not built in the model; disordering of 5–6 has also
been observed in other structures of BTB-domain fragments
that lack the BTB N-terminus (for example, KBTBD4; PDB
entry 2eqx; RIKEN Structural Genomics/Proteomics Initia-
tive, unpublished work). The SPOP C-terminal domain (CTD;
residues 296–359) comprises ﬁve -helices, denoted 7–11,
with 11 residues contributing most of the interactions at the
dimerization interface. The dimer interface buries 685 A˚2 of
surface area per monomer and is stabilized by hydrogen-bond
interactions between Tyr353 and Asn3260 and between Arg354
and Glu3340, together with a salt bridge between Arg354 and
Glu3340. The dimer interface and the 9–10–11 fold are
stabilized by the burial of hydrophobic residues that include
Val349, Ala350, Ala352, Leu356 and Ala357.
To conﬁrm the role of the 11 residues in the high-order
oligomerization of SPOP, we puriﬁed proteins that contained
the entire BTB domain together with various parts of the
C-terminus. SPOP169–359, which contains an intact CTD but
lacks the predicted NLS, eluted as a high-molecular-weight
species upon size-exclusion chromatography and the puriﬁed
protein could be cross-linked into a high-order oligomer;
in contrast, SPOP proteins that had truncations in 11
(SPOP169–344 and SPOP169–355) were dimeric (Supplementary
Fig. 1c). The high-order oligomerization of SPOP is thus
mediated by two independent self-association interfaces: the
classic BTB dimerization interface and the dimerization
interface of the CTD.
3.2. Organization of the SPOP BTB and C-terminal domains
BTB-domain dimers are domain-swapped dimers that have
very low dissociation constants (Kd < 200 nM; Li et al., 1997),
whereas oligomerization directed by the SPOP C-terminus is
dynamic and dissociable in solution (Errington et al., 2012).
In order to obtain protein crystals of the contiguous SPOP
BTB and CTD domains in a single molecule, we therefore
attempted to disrupt CTD dimerization by point mutation of
an interface residue. We mutated Tyr353 to glutamic acid in
the context of the SPOP169–374 protein that contained an intact
BTB and CTD. In contrast to the high-order oligomerization
observed with SPOP169–374, SPOP169–374 Y353E was dimeric
when analysed by size-exclusion chromatography, and
the puriﬁed protein could be cross-linked into a dimer
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Table 1
Data-collection and reﬁnement statistics.
Values in parentheses are for the highest resolution shell.
SPOP270–374 L273D L282D L285K, native SPOP270-374 L273D L282D L285K, SeMet SPOP169–374 Y353E, native
PDB code 4hs2 4j8z
Crystal parameters
Space group P6122 P6122 C121
Unit-cell parameters (A˚, ) a = 57.65, b = 57.65, c = 102.81,
 = 90.00,  = 90.00,  = 120.00
a = 57.58, b = 57.58, c = 102.81,
 = 90.00,  = 90.00,  = 120.00
a = 111.39, b = 71.58, c = 62.22,
 = 90.00,  = 117.21,  = 90.00
Data collection
Resolution (A˚) 51.40–1.53 (1.57–1.53) 51.40–2.12 (2.18–2.12) 58.02–2.42 (2.48–2.42)
Wavelength (A˚) 0.9795 0.9173 0.9763
Rmerge† (%) 5.6 (64.7) 18.5 (89.9) 4.4 (34.6)
Rp.i.m.‡ (%) 1.7 (25.0) 2.9 (15.7) 2.7 (21.6)
hI/(I)i 24.2 (3.1) 38.4 (9.0) 17.2 (3.7)
No. of unique reﬂections 16004 (1143) 6183 (437) 16513 (1207)
Multiplicity 11.6 (8.3) 71.5 (60.1) 3.5 (3.5)
Completeness (%) 99.8 (99.9) 100.0 (100.0) 98.9 (98.1)
Reﬁnement
Resolution (A˚) 27.76–1.53 58.02–2.42
R§ (%) 13.2 20.7
Rfree} (%) 15.1 25.5
R.m.s.d. stereochemistry††
Bond lengths (A˚) 0.011 0.014
Bond angles () 1.17 1.58
No. of protein atoms 542 2762
No. of water molecules 62 25
Average B factor (A˚2) 16.90 64.28
Ramachandran analysis‡‡ (%)
Favoured 100.0 97.7
Allowed 0.0 2.3
Disallowed 0.0 0.0
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the integrated intensity of a given reﬂection and hI(hkl)i is the mean intensity of multiple corresponding
symmetry-related reﬂections. ‡ Rp.i.m. =
P
hklf1=½NðhklÞ  1g1=2
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the integrated intensity of a given reﬂection, hI(hkl)i is the
mean intensity of multiple corresponding symmetry-related reﬂections and N(hkl) is the multiplicity of a given reﬂection. § R =
P
hkl

jFobsj  jFcalcj

=
P
hkl jFobsj, where Fobs and Fcalc
are the observed and calculated structure factors, respectively. } Rfree is as R but calculated using a random 5% of data excluded from reﬁnement. †† R.m.s.d. stereochemistry is the
deviation from ideal values. ‡‡ Ramachandran analysis was carried out using MolProbity (Chen et al., 2010).
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(Supplementary Fig. S1d), conﬁrming the role of Tyr353 in
CTD dimerization and in high-order oligomerization.
We determined the X-ray crystal structure of SPOP169–374 Y353E
at 2.4 A˚ resolution (Table 1 and Fig. 2a). SPOP169–374 Y353E
crystallized as a BTB-mediated dimer; there were no inter-
actions between the CTD residues of neighbouring SPOP
molecules in the crystal, consistent with the complete disrup-
tion of the CTD dimerization interface in the SPOP Y353E
mutant. Residues 177–329 of SPOP169–374 Y353E superposed
extremely well (r.m.s.d. value of 0.49 A˚ for C-atom positions)
with a reported SPOP structure (PDB entry 3htm; SPOP
residues 177–329; Zhuang et al., 2009) that contains the classic
BTB domain (1–6; residues 177–296) together with the
helical hairpin (7–8; residues 300–327) that was dubbed the
3-box (Zhuang et al., 2009). Additionally, residues 300–356
of SPOP169–374 Y353E superposed extremely well with
SPOP270–374 L273D L282D L285K (r.m.s.d. value of 0.46 A˚ for C-
atom positions; Fig. 3a), suggesting that the relative orienta-
tion of the SPOP CTD and BTB domains is inﬂexible. No
electron density was observed for residues 169–176 and 357–
374 of SPOP169–374 Y353E, and residues comprising the 3–4
loop were associated with higher crystallographic B factors, as
reported previously (Zhuang et al., 2009; Errington et al.,
2012).
The 7–8 hairpin of the SPOP CTD interacts with the 5–
6 helices of the BTB domain to form an antiparallel four-
helix bundle, whereas the CTD helices 9–10–11 form a
distinct motif that lies perpendicular to 7–8. The overall
fold of the SPOP CTD resembles the N-terminal portion of
the 130-residue -helical BACK (BTB and C-terminal Kelch)
domain that is found C-terminal to the BTB domain in the
Kelch-type Cul3 adaptors (Stogios & Prive´, 2004). The struc-
ture of SPOP169–374 Y353E superposed well (r.m.s.d value of
2.48 A˚ for C-atom positions) with the contiguous BTB and
BACK domains of the Kelch-type BTB adaptor KLHL11
(PDB entry 3i3n; Canning et al., 2013), with the relative
orientation of the BTB and BACK domains being conserved
between the two proteins (Fig. 2b). The residues preceding 1
of the BTB domain are oriented differently in SPOP and
KLHL11, and interact with different regions of the opposite
chain in the domain-swapped dimer, as reported previously
(Canning et al., 2013; Errington et al., 2012).
3.3. Model of the high-order SPOP oligomer
We generated a model of the high-order SPOP oligomer by
iterative superposition of the dimeric SPOP169–374 Y353E and
SPOP270–374 L273D L282D L285K structures that contain the BTB-
and CTD-interaction interfaces, respectively (Fig. 3a). We also
modelled the substrate-recruiting MATH domains using an
available SPOP structure (PDB entry 3hqi; Zhuang et al.,
2009). The model of the high-order SPOP oligomer depicts
alternating BTB and CTD dimers assembled in a left-handed
helical manner that reﬂects the skewed arrangement of the
constituent twofold-symmetry axes (Figs. 3a and 3b). Although
the extent of high-order oligomerization in vivo is not known,
a full turn of the SPOP helix would contain approximately 16
SPOP chains (eight BTB and eight CTD dimers) and have
a pitch of 510 A˚. The SPOP MATH domains are ﬂexibly
tethered to the BTB domain (Zhuang et al., 2009) and are
organized in a contiguous array along one face of the
oligomer. To conﬁrm the model of the high-order SPOP
oligomer, we visualized the SPOP169–374 complex using atomic
force microscopy (AFM). AFM images depict a linear
organization of the subunits of the SPOPoligomer; most of the
molecules have a curved or horseshoe shape, consistent with a
helical structure that has broken and kinked during the
sequential deposition of its subunits onto the grid (Fig. 3c and
Supplementary Fig. S3).
We also modelled a high-order oligomer of the SPOP E3
ligase complex that contains Cul3 and the E2-binding RING
protein RBX1 (Fig. 3d). This model was generated by super-
position using common regions from available structures: the
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Figure 2
Organization of the SPOP BTB and C-terminal domains. (a) Crystal
structure of the SPOP169–374 Y353E dimer. BTB domains are coloured red
and pink; CTDs are coloured blue and cyan. Secondary-structure
elements of the B chain are indicated. (b) Superposition of
SPOP169–374 Y353E (orange) with the BTB and BACK domains of
KLHL11 (PDB entry 3i3n; green).
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ﬁrst two cullin repeats were from SPOPBTB–Cul3 (PDB entry
4eoz; Errington et al., 2012) and the third cullin repeat and
the cullin C-terminal domain together with RBX1 were from
Cul1–RBX1 (PDB entry 1ldj; Zheng et al., 2002). The model
of the high-order SPOP oligomer is compatible with the
recruitment of a Cul3 molecule to each SPOP chain without
creating steric clashes. The model suggests that the N-terminus
of Cul3 interacts with residues from both the BTB and CTD
domains of SPOP, consistent with a recent structure that
revealed the interaction of Cul3 with both the BTB and BACK
domains of KLHL11 (PDB entry 4ap2; Canning et al., 2013);
the relative orientation of the BTB and Cul3 molecules is
identical in the KLHL11–Cul3 and SPOP–Cul3 structures
(PDB entries 4ap2 and 4eoz, respectively). The elongated
Cul3 molecules extend in arcs away from the SPOP BTB-CTD
backbone to form two rows of arms that bend towards the
inner curve of the helix. The RBX1 molecules that interact
with the C-termini of the cullins to recruit the E2-conjugating
enzyme are thus arranged in two rows that ﬂank the central
MATH domains on the same face of the assembly.
4. Discussion
The model of the high-order SPOP–Cul3–RBX1 oligomer
provides insight into the possible mechanisms whereby
adaptor oligomerization regulates substrate ubiquitination.
The -helical core of the contiguous SPOP CTD and BTB
domains forms a rigid framework upon which multiple -sheet
MATH domains are ﬂexibly tethered along one face. This
arrangement of MATH domains could enhance the efﬁciency
and versatility of substrate recruitment by increasing the rate
of binding and by facilitating simultaneous interactions with
multiple degrons that might be variably positioned within
Figure 3
High-order SPOP oligomers. (a) Superposition of the SPOP CTD dimer (blue and cyan) with the SPOP169–374 Y353E dimer (brown). The rotation axes of
the CTD and BTB domains are indicated. (b) Model of a high-order SPOP oligomer. The model depicts six SPOP molecules and was generated by
iterative superposition of the SPOP CTD dimer with the SPOP169–374 Y353E dimer using structural alignment of the common 7–10 residues (300–344).
BTB domains are coloured red and pink; CTDs are coloured blue and cyan. The SPOP MATH domains (residues 28–166; green) that recruit substrates
for ubiquitination were modelled by superposition from the SPOPBTB+MATH structure (PDB entry 3hqi). (c) AFM images of SPOP169–374 oligomers. A
representative example is shown. The scale bar corresponds to 50 nm. (d) Model of a high-order SPOP–Cul3–RBX1 complex. The SPOP oligomer was
used as a template on which Cul3 and RBX1 were modelled. The ﬁrst two cullin repeats of the Cul3 N-terminal domain were modelled using the
structure of SPOPBTB–Cul3 (PDB entry 4eoz); the third cullin repeat, the cullin C-terminal domain and RBX1 were modelled using the structure of
Cul1–RBX1 (PDB entry 1ldj). Cullin chains are coloured grey and RBX1 chains are coloured magenta.
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a single substrate molecule; such cooperative multivalent
interactions would be particularly important in the recognition
of substrates with multiple weak degrons (Zhang et al., 2009;
Zhuang et al., 2009). The high-order oligomerization of SPOP
would also result in the concentration of multiple E2 conju-
gating enzyme molecules close to the substrate on the same
face of the assembly, thereby increasing the rate of the
ubiquitination reaction.
The mechanisms that modulate the oligomeric state of
SPOP in vivo remain to be determined, although it is feasible
that such regulation might provide a mechanism for the
differential ubiquitination of individual substrates according
to the number and strength of the degrons that they contain. It
has been reported that the SPOP C-terminal region is required
for the ubiquitination and degradation of the substrate Daxx
in transfected mammalian cells (Kwon et al., 2006), consistent
with the importance of high-order oligomerization in vivo.
The human genome encodes a closely related SPOP para-
logue, SPOPL (Choo et al., 2010), that interacts both with
SPOP substrates and with Cul3 in vitro (Errington et al., 2012)
and is highly conserved among vertebrates. The BTB domains
of SPOP and SPOPL are 87% identical and the two proteins
form BTB-mediated heterodimers in vitro; in contrast, the
SPOP and SPOPL CTDs differ, with the SPOPL CTD
containing an 18-residue insertion that prevents high-order
oligomerization (Errington et al., 2012). SPOPL restricts the
high-order oligomerization of SPOP in mixtures of the two
proteins in vitro; this results from the formation of BTB-
mediated hetero-oligomers and it has therefore been specu-
lated that the relative levels of SPOP and SPOPL in vivo
might determine the degree of SPOP oligomerization
(Errington et al., 2012). The dimerization interface of the
SPOP CTD buries a relatively small surface area and can be
completely disrupted by the mutation of Tyr353 to glutamic
acid; it is therefore highly suited for directing the dynamic
high-order association of the more stable BTB-mediated
SPOP dimers and it will be relevant to determine whether
oligomerization is regulated by the phosphorylation of Tyr353
in vivo.
The SPOP CTD resembles the N-terminal portion of the
-helical BACK domain that is found C-terminal to the BTB
domain in the Kelch-type Cul3 adaptors. It is predicted that
Cul3 interacts with the SPOP CTD in a manner that resembles
its interaction with the BACK domain of the Kelch-type
adaptor KLHL11, and the relative orientation of the BTB and
Cul3 molecules is identical in SPOP–Cul3 and KLHL11–Cul3.
It is not known whether the BACK domain mediates high-
order oligomerization of the BTB Kelch-type adaptors: the
Kelch-type adaptors Keap1 and gigaxonin have been reported
as BTB-mediated dimers (Ogura et al., 2010; Zhuang et al.,
2009) and crystal structures of BACK domains have not thus
far revealed self-interaction interfaces (PDB entries 3hve,
2eqx and 3i3n). Thus, although the BTB-mediated SPOP–Cul3
and KLHL11–Cul3 dimers have a similar architecture, the
SPOP CTD may represent a truncated BACK domain that
has evolved an additional specialized function in high-order
oligomerization; it is feasible that differences in the oligo-
merization properties of the individual BTB MATH-type and
Kelch-type Cul3 adaptors have evolved alongside differences
in the modes of substrate recognition and of regulation.
Protein self-assembly provides both architectural and
regulatory roles in biological systems, and high-order oligo-
merization is a feature of proteins that contain more than one
distinct self-association domain. For example, the two inde-
pendent self-association interfaces of the centriole protein,
SAS-6, direct its assembly into a cartwheel structure with
ninefold symmetry that forms the basis of the centriolar core
(Kitagawa et al., 2011). The high-order oligomerization of
BTB-domain proteins has been well documented, although
the structural basis for these associations has thus far
remained elusive. The model of the high-order SPOP oligomer
described here provides a structural basis for the regulation of
substrate ubiquitination by adaptor oligomerization; this will
be relevant for understanding the control of ubiquitination
and may direct the rational design of inhibitors for use in the
therapeutic targeting of ubiquitination complexes.
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